Prostate-specific G-protein coupled receptor, an emerging biomarker regulating inflammation and prostate cancer invasion

Current Molecular Medicine

Volumn 16, Issue 6, 2016, Pages 526-532

  Rodriguez, M ^a   Siwko, S ^a,c   Liu, M ^a,b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b EAST CHINA NORMAL UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Cancer biomarker; G protein coupled receptor; Inflammation; Invasion; Olfactory receptor; Prostate cancer; PSGR

Indexed keywords

G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; OLFACTORY RECEPTOR; OR51E2 PROTEIN, HUMAN; PTEN PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

CANCER SCREENING; CELL INFILTRATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HUMAN; IMMUNOHISTOCHEMISTRY; LUCIFERASE ASSAY; MALE; NONHUMAN; NORTHERN BLOTTING; PCA3 GENE; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PSGR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TUMOR GROWTH; TUMOR INVASION; ADENOCARCINOMA; ANIMAL; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; METABOLISM; MOUSE; OLFACTORY RECEPTOR; PATHOLOGY; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; TRANSGENIC MOUSE;

ADENOCARCINOMA; ANIMALS; BIOMARKERS, TUMOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; MALE; MICE; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; RECEPTORS, ODORANT;

EID: 84981517897     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524016666160607091333     Document Type: Review

References (39)

1. Xu LL, Stackhouse BG, Florence K, et al. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. Cancer Res 2000; 60(23): 6568-72.
2. Horoszewicz JS, Leong SS, Kawinski E, et al. LNCaP model of human prostatic carcinoma. Cancer Res 1983; 43(4): 1809-18.
3. Xia C, Ma W, Wang F, Hua S, Liu M. Identification of a prostate-specific G-protein coupled receptor in prostate cancer. Oncogene 2001; 20(41): 5903-7.
4. Yuan TT, Toy P, McClary JA, Lin RJ, Miyamoto NG, Kretschmer PJ. Cloning and genetic characterization of an evolutionarily conserved human olfactory receptor that is differentially expressed across species. Gene 2001; 278(1-2): 41-51.
5. Weng J, Ma W, Mitchell D, Zhang J, Liu M. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors. J Cell Biochem 2005; 96(5): 1034-48.
6. Avances C, Georget V, Terouanne B, et al. Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens. Mol Cell Endocrinol 2001; 184(1-2): 13-24.
7. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979; 17(1): 16-23.
8. Vaarala MH, Hirvikoski P, Kauppila S, Paavonen TK. Identification of androgen-regulated genes in human prostate. Mol Med Rep 2012; 6(3): 466-72.
9. Peterlin Z, Firestein S, Rogers ME. The state of the art of odorant receptor deorphanization: a report from the orphanage. J Gen Physiol 2014; 143(5): 527-42.
10. Tang XL, Wang Y, Li DL, Luo J, Liu MY. Orphan G proteincoupled receptors (GPCRs): biological functions and potential drug targets. Acta Pharmacol Sin 2012; 33(3): 363-71.
11. Saito H, Chi Q, Zhuang H, Matsunami H, Mainland JD. Odor coding by a Mammalian receptor repertoire. Sci Signal 2009; 2(60): ra9.
12. Pluznick JL, Protzko RJ, Gevorgyan H, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A 2013; 110(11): 4410-5.
13. Neuhaus EM, Zhang W, Gelis L, Deng Y, Noldus J, Hatt H. Activation of an olfactory receptor inhibits proliferation of prostate cancer cells. J Biol Chem 2009; 284(24): 16218-25.
14. Sanz G, Leray I, Dewaele A, et al. Promotion of cancer cell invasiveness and metastasis emergence caused by olfactory receptor stimulation. PLoS One 2014; 9(1): e85110.
15. Jones S, Fernandes NV, Yeganehjoo H, et al. beta-ionone induces cell cycle arrest and apoptosis in human prostate tumor cells. Nutr Cancer 2013; 65(4): 600-10.
16. Dong HW, Zhang S, Sun WG, et al. beta-Ionone arrests cell cycle of gastric carcinoma cancer cells by a MAPK pathway. Arch Toxicol 2013; 87(10): 1797-808.
17. Scolastici C, de Conti A, Cardozo MT, et al. beta-ionone inhibits persistent preneoplastic lesions during the early promotion phase of rat hepatocarcinogenesis: TGF-alpha, NF-kappaB, and p53 as cellular targets. Nutr Cancer 2014; 66(2): 234-41.
18. Liu JR, Dong HW, Sun XR, et al. Effects of beta-ionone on mammary carcinogenesis and antioxidant status in rats treated with DMBA. Nutr Cancer 2010; 62(1): 58-65.
19. Asokkumar S, Naveenkumar C, Raghunandhakumar S, et al. Antiproliferative and antioxidant potential of beta-ionone against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice. Mol Cell Biochem 2012; 363(1-2): 335-45.
20. Jung M, Mo H, Elson CE. Synthesis and biological activity of beta-ionone-derived alcohols for cancer chemoprevention. Anticancer Res 1998; 18(1A): 189-92.
21. De-Oliveira AC, Fidalgo-Neto AA, Paumgartten FJ. In vitro inhibition of liver monooxygenases by beta-ionone, 1,8- cineole, (-)-menthol and terpineol. Toxicology 1999; 135(1): 33-41.
22. Wiese H, Gelis L, Wiese S, et al. Quantitative phosphoproteomics reveals the protein tyrosine kinase Pyk2 as a central effector of olfactory receptor signaling in prostate cancer cells. Biochim Biophys Acta 2015; 1854(6): 632-40.
23. Rodriguez M, Luo W, Weng J, et al. PSGR promotes prostatic intraepithelial neoplasia and prostate cancer xenograft growth through NF-kappaB. Oncogenesis 2014; 3: e114.
24. Spehr J, Gelis L, Osterloh M, et al. G protein-coupled receptor signaling via Src kinase induces endogenous human transient receptor potential vanilloid type 6 (TRPV6) channel activation. J Biol Chem 2011; 286(15): 13184-92.
25. Raming K, Konzelmann S, Breer H. Identification of a novel G-protein coupled receptor expressed in distinct brain regions and a defined olfactory zone. Receptors Channels 1998; 6(2): 141-51.
26. Conzelmann S, Levai O, Bode B, et al. A novel brain receptor is expressed in a distinct population of olfactory sensory neurons. Eur J Neurosci 2000; 12(11): 3926-34.
27. Chang AJ, Ortega FE, Riegler J, Madison DV, Krasnow MA. Oxygen regulation of breathing through an olfactory receptor activated by lactate. Nature 2015; 527(7577): 240-4.
28. Rodriguez M, Siwko S, Zeng L, Li J, Yi Z, Liu M. Prostatespecific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression. Oncogene 2016; 35(9): 1153-62.
29. Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 2010; 24(18): 1967-2000.
30. Weng J, Wang J, Cai Y, et al. Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers. Int J Cancer 2005; 113(5): 811-8.
31. Ashida S, Nakagawa H, Katagiri T, et al. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res 2004; 64(17): 5963-72.
32. Wang J, Weng J, Cai Y, Penland R, Liu M, Ittmann M. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase. Prostate 2006; 66(8): 847-57.
33. Cardillo MR, Di Silverio F. Prostate--specific G protein couple receptor genes and STAG1/PMEPA1 in peripheral blood from patients with prostatic cancer. Int J Immunopathol Pharmacol 2006; 19(4): 871-8.
34. Rigau M, Morote J, Mir MC, et al. PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine. Prostate 2010; 70(16): 1760-7.
35. Rigau M, Ortega I, Mir MC, et al. A three-gene panel on urine increases PSA specificity in the detection of prostate cancer. Prostate 2011; 71(16): 1736-45.
36. Sequeiros T, Bastaros JM, Sanchez M, et al. Urinary biomarkers for the detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia. Prostate 2015; 75(10): 1102-13.
37. Cao W, Li F, Yao J, Yu J. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion. BMC Cancer 2015; 15: 915.
38. Tamura T, Chiba J. Production of antibodies against multipass membrane proteins expressed in human tumor cells using dendritic cell immunization. J Biomed Biotechnol 2009; 2009: 673098.
39. Matsueda S, Wang M, Weng J, et al. Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy. PLoS One 2012; 7(9): e45756.